Evidence map›Paper›PMID 38485491›Full record

ArticleACS infectious diseases2024

Targeting

Karishma Kalera, Rachel Liu, Juhyeon Lim, Rasangi Pathirage, Daniel H Swanson, Ulysses G Johnson, Alicyn I Stothard, Jae Jin Lee, Anne W Poston, Peter J Woodruff and 3 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. A new Persister Enrichment Model inbioRxiv : the preprint server for biology · 2026
    Article
  3. Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026
    Review
  4. Novel Multistage SubunitVaccines · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Mycobacterial Biofilm: Mechanisms, Clinical Problems, and Treatments.International journal of molecular sciences · 2024
    Review
  11. ImmunoTargets and therapy · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Karishma KaleraDepartment of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, Michigan 48859, United States.
Rachel LiuDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States.
Juhyeon LimDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States.
Rasangi PathirageDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.ORCID 0000-0002-8751-8042
Daniel H SwansonDepartment of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, Michigan 48859, United States.
Ulysses G JohnsonDepartment of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, Michigan 48859, United States.
Alicyn I StothardDepartment of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, Michigan 48859, United States.
Jae Jin LeeDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States.
Anne W PostonDepartment of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, Michigan 48859, United States.
Peter J WoodruffDepartment of Chemistry, University of Southern Maine, Portland, Maine 04104, United States.ORCID 0000-0002-3001-7191
Donald R RonningDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.ORCID 0000-0003-2583-8849
Hyungjin EohDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, United States.
Benjamin M SwartsDepartment of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, Michigan 48859, United States.ORCID 0000-0001-8402-359X
Central Michigan University · USUniversity of Southern California · USUniversity of Nebraska Medical Center · USUniversity of Southern Maine · US

Funding

Understanding trehalose synthesis and utilization in mycobacteriaR01AI105084 · NIAID · UNIVERSITY OF TOLEDO · PI RONNING, DONALD R, SUCHECK, STEVEN · 2013 to 2022
$3.7M
Interplay of M. tuberculosis trehalose metabolism and its pathogenesis and drug resistanceR01AI168088 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Hyungjin Eoh · 2023 to 2026
$2.6M
Chemoenzymatic synthesis of trehalose analogues as tools for investigating mycobacteriaR15AI117670 · NIAID · CENTRAL MICHIGAN UNIVERSITY · PI SWARTS, BENJAMIN MICHAEL, WOODRUFF, PETER J · 2015 to 2024
$1.3M
Metabolic compensation in Mycobacterium tuberculosis for the formation of persistersR21AI139386 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EOH, HYUNGJIN · 2019 to 2020
$454k
NIAID NIH HHS R01 AI105084NIAID NIH HHS R01 AI168088NIAID NIH HHS R15 AI117670NIAID NIH HHS R21 AI139386
6 · The paper itself

Abstract

Tuberculosis (TB), caused by

Indexed as

Mycobacterium tuberculosisTuberculosisCatalysisCryoelectron MicroscopyHumansTrehaloseTrehalose

Identifiers

PMID38485491
PMCPMC11019547
OpenAlexW4392863442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.